Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan-Reference-Cited by-同舟云学术

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Published:2007-02 Issue:2 Volume:18 Page:317-323
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ohe Y.,Ohashi Y.,Kubota K.,Tamura T.,Nakagawa K.,Negoro S.,Nishiwaki Y.,Saijo N.,Ariyoshi Y.,Fukuoka M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/2/317/694598/mdl377.pdf

Reference32 articles.

1. The Editorial Board of the Cancer Statistics in Japan;Cancer Statistics in Japan 2005,2005

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995

3. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer;Fukuoka;J Clin Oncol,1992

4. Paclitaxel (taxol);Rowinsky;N Engl J Med,1995

5. The taxoids: paclitaxel and docetaxel;Gelmon;Lancet,1994

Cited by 539 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between pathological infiltrative tumor growth pattern and prognosis in patients with resected lung squamous cell carcinoma;European Journal of Surgical Oncology;2024-03

2. Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer;Cancer Letters;2024-02

3. Forkhead box proteins as the critical regulators of cisplatin response in tumor cells;European Journal of Pharmacology;2023-10

4. The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation;Indian Journal of Medical and Paediatric Oncology;2023-09-27

5. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease;Translational Lung Cancer Research;2023-08